# Evaluation of a Novel Closed-loop Propofol and Remifentanil System Guided by Bispectral Index Compared to a TCI Open-loop System

> **NCT02492282** · PHASE3 · COMPLETED · sponsor: **Universidad de Antioquia** · enrollment: 150 (actual)

## Conditions studied

- Anesthesia, General
- Anesthesia, Intravenous

## Interventions

- **DEVICE:** Closed-Loop propofol and remifentanil system by Bispectral Index
- **DEVICE:** Open-Loop propofol and remifentanil by Target Controlled Infusion
- **DRUG:** propofol

## Key facts

- **NCT ID:** NCT02492282
- **Lead sponsor:** Universidad de Antioquia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-12
- **Final completion:** 2016-04
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2016-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02492282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02492282, "Evaluation of a Novel Closed-loop Propofol and Remifentanil System Guided by Bispectral Index Compared to a TCI Open-loop System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02492282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*